Product Information

VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1043 per EA under NDC 33342007515. Its NADAC has been published 623 times since Jun 18, 2014.

FDA first approved this application on Apr 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB

Valsartan and Hydrochlorothiazide
$0.1043per EA

Strength

12.5; 160 mg/1; mg/1

NDC

33342007515

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA203145

FDA Approved

4/19/2013

TE Code

AB

On Market Since

4/19/2013

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB has been published 623 times since Jun 18, 2014, and over the history we have for it it has declined 60.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1043 per EA
All-time high$0.4405 (Jun 10, 2020)
All-time low$0.1014 (Sep 23, 2026)
52-week high$0.1448
52-week low$0.1014
Median price$0.1982
Average price$0.2125
Largest weekly change+31.2% (May 20, 2020)
Weeks tracked623
Tracking sinceJun 18, 2014

Price History

1W

+0.1%

1M

+2.9%

3M

+1.5%

6M

-13.7%

1Y

-28.0%

3Y

-44.4%

5Y

-67.3%

All

-60.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.1043 per EA (NDC 33342007515), effective Nov 18, 2026.

How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB has declined 60.7%. It has been tracked across 623 weekly CMS publications since Jun 18, 2014.

What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB?

Since Jun 18, 2014, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB has ranged from a low of $0.1014 (Sep 23, 2026) to a high of $0.4405 (Jun 10, 2020), with a median of $0.1982 per EA.

Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB?

VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB (NDC 33342007515) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.